Barinthus Bio to Cut Workforce 25% to Focus on Hepatitis, Celiac Treatments After Positive Data; Shares Rise After Hours
Barinthus Bio to Cut Workforce 25% to Focus on Hepatitis, Celiac Treatments After Positive Data; Shares Rise After Hours
Barinthus Bio將裁員25%，專注於乙肝和乳糜瀉治療，因積極數據後股價在盤後上漲。
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登入免費觀看全文
登入/註冊